---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-26-004190"
form_type: "8-K"
ticker: "XFLH"
cik: "0002088103"
company_name: "XFLH Capital Corp"
filed_at: "2026-09-22T12:30:22+00:00"
generated_at: "2026-09-22T12:35:16.941002+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# XFLH Capital signs non-binding LOI to combine with Renogen Biolab

## Summary
- On Sept 18, 2026, XFLH Capital entered a non-binding letter of intent for a business combination with Renogen Biolab Inc., a Canadian health service provider.
- Renogen Biolab offers DNA services, vector engineering, and protein expression; parties will negotiate definitive agreements with due diligence access.
- No deal value, premium, or closing conditions disclosed; the LOI is non-binding and subject to negotiation of Definitive Agreements.
- XFLH is a Cayman Islands blank-check SPAC; its units, ordinary shares, and rights trade on NYSE under XFLHU, XFLH, XFLHR.

## SEC filing metadata
- accession: 0001185185-26-004190
- form_type: 8-K
- ticker: XFLH
- cik: 0002088103
- company_name: XFLH Capital Corp
- filed_at: 2026-09-22T12:30:22+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2088103/000118518526004190/0001185185-26-004190-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2088103/000118518526004190/xflh8k021326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-26-004190
- JSON: https://secwatch.observer/filing/0001185185-26-004190.json
- Plain text: https://secwatch.observer/filing/0001185185-26-004190.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.